That’s why we have developed the CardioCheck by myritmo for you for only:
19,90 €
incl. statutory value added tax
This is how it works:
Send us your ECG data directly by e-mail to: cardio@myritmo.com
Please send us only one ECG file (PDF)
per e-mail!
You will immediately receive a confirmation of receipt by e-mail. This will contain a link to the order form on our website. Please complete your order and payment there.
Upon receipt of your payment, analysis of your ecg data will immediately begin. You will receive your report by e-mail within one business day*.
Dr. med. Stephan Kranz
Medical Managing Director
Our experienced physicians have developed CardioCheck by myritmo to analyze ECG data.
We have received several awards for our products and our partners rely on our expert diagnostics.
Our cooperation partners:
What should I do if my smartwatch shows an ECG abnormality?
Many smartwatches or fitness trackers record short-term ECGs and can therefore indicate the presence of dangerous atrial fibrillation. A medically sound monitoring.
Approximately 1.1 million inhabitants of Europe suffered a stroke each year. Atrial fibrillation is the number one risk for strokes: it increases the risk of a stroke by around 5 times. It is estimated that 7.6 million people over 65 in the EU had atrial fibrillation in 2016 – mostly unrecognized – and this will increase by 89% to 14.4 million by 2060.
In the case of atrial fibrillation, a specialist assessment is urgently required. But in our overburdened healthcare system, this can take a long time – often too long.
To close this gap in care, we have developed CardioCheck by myritmo. Simply forward your ECG recording from your device by email to cardio@myritmo.com – and you will receive your ecg report the very next working day.
Would you like a more intensive CardioCheck?
To reliably clarify indications of other cardiac arrhythmias or atrial fibrillation, a long-term ECG is still recommended. This records your heart activity with at least 3 channels in order to obtain medically reliable data. Wearables only have 1 channel, which only measures the heartbeats over 30 seconds. They are therefore significantly less accurate.
Our mini ECG myritmo – a wireless, passport photo-sized device – records your heart activity over 72 hours and thus provides a detailed picture of your heart health: quickly, reliably and safely. We therefore recommend heart screening with myritmo.
Our mission is to prevent strokes!
From treatment to prevention
Hundreds of thousands of people in Germany live with cardiac arrhythmia without realising it because the prevailing long-term ECG is time-consuming, labour-intensive and costly. Many secondary diseases, such as strokes, are not prevented in time. With serious consequences for patients – but also for health insurance companies and the community. We want to and will change this.
Our doctors have set themselves the goal of using the possibilities of modern digital technology to break new ground in diagnostics.
Wearables are a particularly low-threshold screening option for everyone. The wristbands with built-in intelligent computer technology can do more and more: they record vital parameters such as pulse, heart rate and oxygen saturation, record atrial fibrillation and cardiac arrhythmia. Wearables are convenient for everyone to use and this ECG data can be analysed quickly and safely at any time by CardioCheck. We are proud to be able to offer CardioCheck by myritmo to everyone in an uncomplicated and cost-effective way.
*Working days are Monday to Friday excluding public holidays.
Your data will only be processed in compliance with data protection regulations for the purpose of screening for atrial fibrillation and other cardiac arrhythmias in accordance with your consent.
The CardioCheck is only available to people over the age of 18, as this service is intended for adult users.
Disclaimer
Legal Basis: Scope of Services, Liability, Treatment and Medical Discretion
dpv-analytics GmbH provides the user with a graphically presented summary of the transmitted ECG data (“CardioCheck Report”). This CardioCheck Report is intended exclusively for the user’s self-monitoring of their own health data and does not replace a medical examination, consultation, and/or diagnosis. The content of the CardioCheck Report is generated by medically certified software. The program compares the submitted user and ECG data with the target values defined as the normal range in medical literature and cardiology guidelines, thereby determining the statistical risk of a cardiac condition based on these values. The CardioCheck report is not suitable for an individual evaluation or assessment of vital signs. A “green” risk indicates a statistically normal value but does not rule out the presence of a risk or disease. A “yellow” or “red” risk merely indicates statistical abnormalities but does not provide a diagnosis of a pathological condition. dpv-analytics GmbH conducts random quality control checks of the generated results using medically trained personnel. There is no individual review of the CardioCheck report.
dpv-analytics GmbH is liable for damages only to the extent that they result from a breach of a material contractual obligation or from intentional or grossly negligent conduct on the part of its legal representatives or agents. Excluded from this limitation of liability are damages resulting from injury to life, body, or health. Mandatory liability under the Product Liability Act also remains unaffected by this exclusion of liability. dpv-analytics GmbH prohibits any unauthorized use of the CardioCheck report by physicians. The CardioCheck report does not contain any medical findings; physicians may not use the CardioCheck report as the basis for a diagnosis or treatment.
Company address: DPV-Analytics GmbH – Schloßstraße 12 – 22041 Hamburg
As of: 2026